Table 3: ART use by clinical characteristics.

ART use prior to ICU admission ART use during ICU stay
Yes
N = 104
No
N = 121
p-value ARV discontinued
N = 45
ARV initiated
N = 10
ART continued
N = 54
No ART Usea
N = 129
p-value
CD4 (Median (IRb)) 179.0 (348) 43 (254) 0.000 181 (844) 10 (417) 201 (538) 45 (763) < 0.05
Length of stay (Median (IR) 3.0 (6.0) 3.0 (65.0) 0.140 3.0 (6.0) 3.50 (35.0) 3.0 (6.0) 3.0 (5.0) 0.561
APACHE II score (Mean ± SD) 16.9 ± 9 15.3 ± 11 0.210 19 ± 9.3 14.4 ± 4.8 15.0 ± 6.9 16.6 ± 9.4 0.206
AIDS defining diagnosis (%)
    Yes
    No

30.0
55.7

70.0
47.3

0.02

9.6
23.4

7.72.8

15.4
29.0

67.3
44.8

0.006
Co-morbidities ( %Yes)
    Psychiatric disorders
    Cardiovascular disorder
    Hepatic disorders
    Renal disorders
    Respiratory disorders
    Neurological disorders
    Endocrine disorders
    Substance abuse

40.0
51.5
48.5
52.5
46.3
52.6
41.9
43.7

60.0
48.5
51.5
57.5
56.7
47.4
58.1
56.3

0.439
0.139
0.627
0.235
0.959
0.543
0.546
0.635

10.8
21.8
22.5
18.5
18.6
28.6
25.0
19.2

0.0
3.0
4.2
7.7
2.3
4.8
0.0
5.1

24.3
27.7
23.9
30.8
25.6
19.0
18.2
17.9

64.9
47.5
49.3
43.1
53.5
47.6
56.8
57.7

0.222
0.201
0.765
0.070
0.889
0.695
0.274
0.633
ICU admission diagnosis (%)
    AMS
    Respiratory/Pneumonia
    Gastrointestinal
    Sepsis/Shock
    Cardiovascular related
    Metabolic disturbances
    Liver failure
    Renal failure

36.4
44.9
27.8
50.0
56.5
53.8
75.0
25.0

63.6
55.1
72.2
50.0
43.5
46.2
25.5
75.0

0.329
0.767
0.102
0.695
0.296
0.570
0.338
0.626

21.7
16.9
16.7
11.5
12.5
38.5
50.0
0.0

4.3
3.6
5.6
7.7
4.2
7.7
0.0
0.0

17.4
20.5
11.1
23.1
41.7
23.1
25.0
25.0

56.5
59.0
66.7
57.7
41.7
30.8
25.0
75.0

0.930
0.751
0.605
0.625
0.133
0.206
0.407
0.735
Mortality in the ICU (%)
    Survived
    Died

45.4
51.3

54.6
48.7

0.596

17.8
24.0

4.3
4.0

24.9
14.0

53.0
58.0

0.386

aThese were defined as patients who came in without ART and did not receive any ART while in the ICU; bIR = Interquartile range.